Related Experiment Videos
Surgery for pulmonary metastasis: a 20-year experience
The Annals of Thoracic Surgery
|October 1, 1984
Summary
Surgical removal of pulmonary metastasis offers a 35% overall survival rate. Strict patient selection is crucial for successful outcomes, with adjuvant therapies potentially improving results for specific sarcoma patients.
Area of Science:
- Surgical Oncology
- Thoracic Surgery
- Cancer Metastasis Research
Background:
- Pulmonary metastasis poses a significant challenge in cancer management.
- Surgical resection is a potential treatment modality for selected patients with lung metastases.
Purpose of the Study:
- To evaluate the efficacy and outcomes of surgical intervention for pulmonary metastasis.
- To identify factors influencing survival after pulmonary metastasectomy.
Main Methods:
- Retrospective analysis of 556 patients undergoing surgery for pulmonary metastasis over 20 years.
- Inclusion criteria focused on complete disease removal and primary tumor control.
- Evaluation of adjunctive therapies and their impact on survival.
Main Results:
- Overall survival was 35% with a surgical mortality of 1.5%.
- Survival rates varied by primary tumor type, ranging from 24% (cervix) to 54% (urinary tract, male genital, uterine corpus).
- Adjuvant treatment showed a survival advantage, particularly for sarcoma patients.
Conclusions:
- Surgical resection of pulmonary metastasis can be successful with strict adherence to selection criteria.
- Systemic adjuvant treatment is necessary to improve outcomes when complete disease control is not achieved surgically.
- Further research into optimizing adjuvant therapies for pulmonary metastasis is warranted.